Investor mix
3 investors on record; lead investors include Sears Capital Management, SCRA.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 2 | 67% |
| Accelerator & incubator | 1 | 33% |
Developing anti-nucleolin antibodies for broad-spectrum cancer therapy
3 investors on record; lead investors include Sears Capital Management, SCRA.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 2 | 67% |
| Accelerator & incubator | 1 | 33% |